Lung Cancer
Conference Coverage
Adagrasib shows durable benefit in KRAS-mutated NSCLC
“Our patients benefited clinically from this agent, and it appears to have improved overall survival.”
News
Immunotherapy treatment combo charts new course for resectable NSCLC treatment
Three cycles of neoadjuvant nivolumab plus chemotherapy improved long-term clinical outcomes in resectable stage IB-IIIA NSCLC.
News
Can lung cancer ID be as easy as breathing into an analyzer?
Breathomics testing is considered a promising lung cancer screening tool.
News
Some smokers don’t get lung cancer; genetics might explain it
These people have genes that help limit mutations to DNA that would turn cells malignant and make them grow into tumors.
News
Improved cancer survival in states with ACA Medicaid expansion
The 2-year overall survival increased from 80.6% before the ACA to 82.2% post ACA in expansion states and from 78.7% to 80% in nonexpansion states...
Article
Applicability of the USPSTF Lung Cancer Screening Guidelines in a Predominantly Black Veteran Population
This retrospective chart review examined the efficacy of the 2013 United States Preventive Services Task Force lung cancer screening guidelines in...
News
Women with lung cancer live longer than men
“In this first Australian prospective study of lung cancer survival comparing men and women, we found that men had a 43% greater risk of dying...
Opinion
Dodging potholes from cancer care to hospice transitions
The consequences of suboptimal hospice transitions can damage the mental health and well-being of patient and caregiver.
News
Fifth COVID shot recommended for patients with cancer
Conference Coverage
Preop nivolumab plus chemo ‘a quantum leap’ in NSCLC therapy
The combination resulted in significantly longer event-free survival.
